MAYS J W INC (MAYS) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-04-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-04-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-04-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-04-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-04-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 21.43M USD | |
| Stock-based compensation | (m) | |
| Operating income | -1.66M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | (m) | $21.43M | (m) | $-1.66M | (m) | (m) | (m) | (m) | (m) |
| 2026-01-31 | (m) | $21.75M | (m) | $-1.22M | (m) | (m) | (m) | (m) | (m) |
| 2025-10-31 | (m) | $22.18M | (m) | $-694.68K | (m) | (m) | (m) | (m) | (m) |
| 2025-07-31 | (m) | $22.47M | (m) | $-154.33K | (m) | (m) | (m) | (m) | (m) |
| 2025-04-30 | (m) | $22.31M | (m) | $-100.55K | (m) | (m) | (m) | (m) | (m) |
| 2025-01-31 | (m) | $22.04M | (m) | $-370.36K | (m) | (m) | (m) | (m) | (m) |
| 2024-10-31 | (m) | $21.81M | (m) | $-516.28K | (m) | (m) | (m) | (m) | (m) |
| 2024-07-31 | (m) | $21.59M | (m) | $-620.11K | (m) | (m) | (m) | (m) | (m) |
| 2024-04-30 | (m) | $21.51M | (m) | $-654.28K | (m) | (m) | (m) | (m) | (m) |
| 2024-01-31 | (m) | $21.71M | (m) | $-521.62K | (m) | (m) | (m) | (m) | (m) |
| 2023-10-31 | (m) | $22.13M | (m) | $-143.57K | $209.68K | (m) | (m) | -0.68× | Reported |
| 2023-07-31 | (m) | $22.58M | (m) | $223.67K | $230.77K | (m) | (m) | 0.97× | Reported |
| 2023-04-30 | (m) | $22.68M | (m) | $284.77K | $238.15K | (m) | (m) | 1.20× | Reported |
| 2023-01-31 | (m) | $22.60M | (m) | $326.08K | $227.03K | (m) | (m) | 1.44× | Reported |
| 2022-10-31 | (m) | $22.09M | (m) | $64.54K | $234.21K | (m) | (m) | 0.28× | Reported |
| 2022-07-31 | (m) | $21.40M | (m) | $-657.01K | $251.98K | (m) | (m) | -2.61× | Reported |
| 2022-04-30 | (m) | $21.06M | (m) | $-506.83K | $203.70K | (m) | (m) | -2.49× | Reported |
| 2022-01-31 | (m) | $20.74M | (m) | $-766.34K | $256.46K | (m) | (m) | -2.99× | Reported |
| 2021-10-31 | (m) | $20.46M | (m) | $-882.65K | $260.41K | (m) | (m) | -3.39× | Reported |
| 2021-07-31 | (m) | $20.21M | (m) | $-837.78K | $265.58K | (m) | (m) | -3.15× | Reported |
| 2021-04-30 | (m) | $19.37M | (m) | $-1.64M | $349.39K | (m) | (m) | -4.68× | Reported |
| 2021-01-31 | (m) | $19.34M | (m) | $-1.88M | $315.79K | (m) | (m) | -5.94× | Reported |
| 2020-10-31 | (m) | $19.33M | (m) | $-1.78M | $260.68K | (m) | (m) | -6.85× | Reported |
| 2020-07-31 | (m) | $19.53M | (m) | $-1.24M | $202.52K | (m) | (m) | -6.12× | Reported |
| 2020-04-30 | (m) | $19.92M | (m) | $237.01K | $186.82K | (m) | (m) | 1.27× | Reported |
| 2020-01-31 | (m) | $20.07M | (m) | $1.37M | $165.76K | (m) | (m) | 8.24× | Reported |
| 2019-10-31 | (m) | $20.35M | (m) | $2.03M | $188.17K | (m) | (m) | 10.77× | Reported |
| 2019-07-31 | (m) | $20.48M | (m) | $1.82M | $200.59K | (m) | (m) | 9.06× | Reported |
| 2019-04-30 | (m) | $20.11M | (m) | $1.70M | $162.56K | (m) | (m) | 10.48× | Reported |
| 2019-01-31 | (m) | $19.86M | (m) | $1.49M | $175.62K | (m) | (m) | 8.48× | Reported |
| 2018-10-31 | (m) | $19.51M | (m) | $1.14M | $180.36K | (m) | (m) | 6.34× | Reported |
| 2018-07-31 | (m) | $19.30M | (m) | $1.85M | $233.47K | (m) | (m) | 7.94× | Reported |
| 2018-04-30 | (m) | (m) | (m) | $2.04M | $244.89K | (m) | (m) | 8.34× | Reported |
| 2018-01-31 | (m) | (m) | (m) | $2.54M | $250.91K | (m) | (m) | 10.11× | Reported |
| 2017-10-31 | (m) | (m) | (m) | $2.97M | $257.04K | (m) | (m) | 11.56× | Reported |
| 2017-07-31 | (m) | (m) | (m) | $3.04M | $225.94K | (m) | (m) | 13.45× | Reported |
| 2017-04-30 | (m) | (m) | (m) | $2.90M | $220.25K | (m) | (m) | 13.17× | Reported |
| 2017-01-31 | (m) | (m) | (m) | $2.70M | $209.87K | (m) | (m) | 12.88× | Reported |
| 2016-10-31 | (m) | (m) | (m) | $2.56M | $219.81K | (m) | (m) | 11.67× | Reported |
| 2016-07-31 | (m) | (m) | (m) | $2.51M | $222.51K | (m) | (m) | 11.28× | Reported |
| 2016-04-30 | (m) | (m) | (m) | $2.62M | $207.77K | (m) | (m) | 12.62× | Reported |
| 2016-01-31 | (m) | (m) | (m) | $2.70M | $237.58K | (m) | (m) | 11.38× | Reported |
| 2015-10-31 | (m) | (m) | (m) | $2.99M | $271.05K | (m) | (m) | 11.03× | Reported |
| 2015-07-31 | (m) | (m) | (m) | $3.19M | $315.17K | (m) | (m) | 10.11× | Reported |
| 2015-04-30 | (m) | (m) | (m) | $2.67M | $369.83K | (m) | (m) | 7.23× | Reported |
| 2015-01-31 | (m) | (m) | (m) | $2.26M | $412.36K | (m) | (m) | 5.49× | Reported |
| 2014-10-31 | (m) | (m) | (m) | $1.64M | $433.16K | (m) | (m) | 3.78× | Reported |
| 2014-07-31 | (m) | (m) | (m) | $1.47M | $423.01K | (m) | (m) | 3.48× | Reported |
| 2014-04-30 | (m) | (m) | (m) | $1.48M | $421.79K | (m) | (m) | 3.50× | Reported |
| 2014-01-31 | (m) | (m) | (m) | $1.36M | $413.90K | (m) | (m) | 3.27× | Reported |
| 2013-10-31 | (m) | (m) | (m) | $1.31M | $411.01K | (m) | (m) | 3.19× | Reported |
| 2013-07-31 | (m) | (m) | (m) | $1.53M | $426.32K | (m) | (m) | 3.60× | Reported |
| 2013-04-30 | (m) | (m) | (m) | $2.22M | $435.79K | (m) | (m) | 5.10× | Reported |
| 2013-01-31 | (m) | (m) | (m) | $2.92M | $456.94K | (m) | (m) | 6.39× | Reported |
| 2012-10-31 | (m) | (m) | (m) | $3.60M | $484.94K | (m) | (m) | 7.42× | Reported |
| 2012-07-31 | (m) | (m) | (m) | $3.29M | $522.76K | (m) | (m) | 6.30× | Reported |
| 2012-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-07-31 | (m) | (m) | (m) | $1.88M | $652.83K | (m) | (m) | 2.88× | Reported |
| 2011-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-07-31 | (m) | (m) | (m) | $1.79M | $723.75K | (m) | (m) | 2.48× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gyrodyne, LLC (GYRO) | United States | $0.011B | |
| Piedmont Realty Trust, Inc. (PDM) | United States | $1.149B | -9.51 |